Skip to main content
HR 4553 116th Congress House

Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act

Official title: To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome, Nipah, and Rift Valley fever.

Introduced: September 27, 2019 Introduced by: Boyle, Brendan F. Democratic · Pennsylvania See on congress.gov
Health Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationDrug therapyInfectious and parasitic diseases
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 2019
Referred to the Subcommittee on Health.
Sep 27, 2019
Introduced in House
Sep 27, 2019
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action September 30, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act

This bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 1 Republican 2
R
Steil, Bryan
Wisconsin · Oct 31, 2019
Fortenberry, Jeff
· Sep 27, 2019
 R
Marshall, Roger
Kansas · Sep 27, 2019
 D
Veasey, Marc A.
Texas · Sep 27, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4553: Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4553/
MLA
"H.R. 4553: Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4553/.
Bluebook (legal)
H.R. 4553, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4553/.
Markdown link
[H.R. 4553: Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act](https://openamerica.io/bill/116-HR-4553/)
Report a problem